Literature DB >> 10797298

Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns.

A A Alaiya1, B Franzén, A Hagman, C Silfverswärd, B Moberger, S Linder, G Auer.   

Abstract

Large amounts of data on quantitative gene expression are generated by procedures such as 2-DE analysis of proteins or cDNA microarrays. Quantitative molecular variation may potentially be used for the development of methods for the classification of tumors. We used here the statistical concepts of principal components analysis (PCA) and partial least square analysis (PLS) in an attempt to type ovarian tumors. Using a set of 170 polypeptides, 22 tumors were used to establish a model ("learning set") for classification into 3 groups (benign/borderline/malignant). Eighteen tumors were then used to test the model. Six of 8 carcinomas and 3 of 4 borderline tumors were correctly classified. Two of 6 benign lesions were correctly classified, 3 were classified as borderline and 1 as carcinoma. We conclude that it may be possible to classify tumors according to their constitutive protein expression profile using multivariate analysis, thus making classification by artificial intelligence a future possibility. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797298     DOI: 10.1002/(sici)1097-0215(20000601)86:5<731::aid-ijc20>3.0.co;2-a

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Multivariate meta-analysis of proteomics data from human prostate and colon tumours.

Authors:  Lina Hultin Rosenberg; Bo Franzén; Gert Auer; Janne Lehtiö; Jenny Forshed
Journal:  BMC Bioinformatics       Date:  2010-09-17       Impact factor: 3.169

3.  Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis.

Authors:  U J Roblick; F G Bader; C Lenander; U Hellman; K Zimmermann; S Becker; A Ost; A Alaiya; H-P Bruch; R Keller; L Mirow; B Franzén; T Ried; G Auer; J K Habermann
Journal:  Int J Colorectal Dis       Date:  2008-02-22       Impact factor: 2.571

4.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 5.  Progress in the application of DNA microarrays.

Authors:  E K Lobenhofer; P R Bushel; C A Afshari; H K Hamadeh
Journal:  Environ Health Perspect       Date:  2001-09       Impact factor: 9.031

6.  The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing = different lists of significant proteins.

Authors:  Sreelatha Meleth; Jessy Deshane; Helen Kim
Journal:  BMC Biotechnol       Date:  2005-02-11       Impact factor: 2.563

7.  The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum.

Authors:  Abdulaziz Alsemari; Fahad Alkhodairy; Ahmad Aldakan; Mai Al-Mohanna; Eman Bahoush; Zakia Shinwari; Ayodele Alaiya
Journal:  BMC Complement Altern Med       Date:  2014-03-29       Impact factor: 3.659

8.  Protein expression patterns in primary carcinoma of the vagina.

Authors:  K Hellman; A A Alaiya; K Schedvins; W Steinberg; A-C Hellström; G Auer
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

9.  Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients.

Authors:  Ayodele A Alaiya; Mahmoud Aljurf; Zakia Shinwari; Fahad Almohareb; Hafiz Malhan; Hazzaa Alzahrani; Tarek Owaidah; Jonathan Fox; Fahad Alsharif; Said Y Mohamed; Walid Rasheed; Ghuzayel Aldawsari; Amr Hanbali; Syed Osman Ahmed; Naeem Chaudhri
Journal:  Int J Oncol       Date:  2016-07-07       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.